Insurance Daily News

Study Finds 75% CTE Prevalence in Deceased NFL Players

A recent study conducted by researchers at Boston University, in collaboration with Mass General Brigham and the Concussion & CTE Foundation, has revealed that approximately 75% of former NFL players who passed away between 2008 and 2023 exhibited signs of chronic traumatic encephalopathy (CTE). Published in JAMA Network Open, the findings offer a significant update to previous estimates, which had ranged widely from 25% to 98% for players who died between 2016 and 2021. The researchers emphasized that these figures apply specifically to postmortem analysis and cannot be used to predict the prevalence of the disease in living individuals or active athletes.

The methodology of this latest study marks a departure from earlier research, which faced criticism regarding selection bias. Previous estimates were often based on brains donated by individuals who were more likely to have experienced symptoms while alive, potentially skewing the data. To address this, the current study analyzed 2,362 cases. This dataset combined information from 396 players who donated their brains with National Death Index records of 1,966 deceased players who did not. By incorporating a broader range of data, the researchers sought to create a more accurate representation of the NFL population.

CTE is a neurodegenerative condition linked to repetitive head impacts and currently requires a postmortem examination for a definitive diagnosis. Lead author Julia Gallini, a PhD candidate at the Boston University School of Public Health, noted that while not every individual with CTE pathology will manifest symptoms, the 75% prevalence rate is significant when compared to the less than 1% prevalence found in community brain bank donors. Common symptoms for those who do develop the disease include cognitive impairment, behavioral changes, and dementia. Notably, previous research has indicated that NFL players experience dementia at four times the rate of the general population.

Contextually, this research highlights the critical role of data integrity in longitudinal health studies. For the informatics and research community, the shift from relying solely on symptomatic donor cohorts to integrating broader death index records demonstrates an evolving approach to mitigating selection bias in medical research. As the industry moves toward better diagnostic tools, the ability to synthesize disparate datasets—such as brain bank donations and national mortality records—is becoming essential for understanding the long-term health impacts of high-impact sports.

The implications for the sports industry are substantial. The NFL and the NFL Players Association have both acknowledged the importance of this research in understanding the long-term effects of football. The league continues to implement strategies aimed at reducing head impacts, while stakeholders like former NFL quarterback Matt Hasselbeck have emphasized the necessity of using this data to improve player safety for future generations. With the history of legal settlements, such as the 2013 NFL agreement and the 2018 NHL settlement, the pressure to translate these research findings into actionable medical and safety protocols remains high.

Looking ahead, the focus for the scientific community will likely shift toward the challenge of diagnosing CTE in living patients. As researchers continue to refine their methodologies, the integration of advanced diagnostic software and longitudinal health tracking will be key areas to watch. The goal remains to move beyond postmortem confirmation toward early detection and symptom management, which could fundamentally change how the medical community approaches neurodegenerative risks in contact sports.

Why it matters

This study demonstrates how improved data integration and the mitigation of selection bias can provide a more accurate understanding of long-term health risks in professional sports, highlighting the ongoing need for better diagnostic tools for living patients.

FAQ

What is the primary finding of the Boston University study?
The study found that approximately 75% of NFL players who died between 2008 and 2023 had CTE neuropathology.

How did this study address previous criticisms regarding selection bias?
Researchers combined data from 396 brain donors with National Death Index records of 1,966 deceased players who did not donate, rather than relying solely on brains from symptomatic donors.

Can this study predict if a living player has CTE?
No, the researchers cautioned that the findings apply only to deceased players and cannot predict the prevalence of CTE in living or active athletes.

Source: Insurance Journal. See the original source for full details.